| Literature DB >> 32303433 |
Maurício de Quadros1, Roberto Carlos Freitas Bugs2, Renata de Oliveira Soares2, Adriana Medianeira Rossato2, Lisiane da Luz Rocha2, Pedro Alves d'Azevedo2.
Abstract
BACKGROUND: The increasingly frequent use of dermoscopy makes us think about the possibility of transfer of microorganisms, through the dermatoscope, between doctor and patients.Entities:
Keywords: Dermoscopy; Gram-positive cocci; Mass spectrometry; Microbial sensitivity tests
Mesh:
Substances:
Year: 2020 PMID: 32303433 PMCID: PMC7253918 DOI: 10.1016/j.abd.2019.11.004
Source DB: PubMed Journal: An Bras Dermatol ISSN: 0365-0596 Impact factor: 1.896
Figure 1Sample of dermatologist's flowchart.
Characteristics of the dermatologists in the sample and the use of the dermatoscope.
| Variable | Descriptive measures |
|---|---|
| 36.4 ± 8.4 | |
| Male | 16 (13.5) |
| Female | 102 (86.5) |
| Time as a dermatologist, median – years (interquartile range) | 6.5 (2 |
| In the private office | 47 (39.8) |
| At hospital | 25 (21.2) |
| In the private office and at hospital | 46 (39) |
| Number of times the dermatoscope id used per day – median (interquartile range) | 15 (10 |
| Amount of time the dermatoscope is used during consultation, in minutes – median (interquartile range) | 5 (3 |
| DL100 | 6 (5.1) |
| DL200 | 2 (1.7) |
| DL3 | 24 (20.3) |
| DL4 | 34 (28.8) |
| Hybrid | 42 (35.6) |
| MiniHeine or Heine | 8 (6.8) |
| Wellch Allyn | 1 (0.8) |
| Veos Canfield | 1 (0.8) |
| Yes | 92 (78) |
| No | 26 (22) |
| Coat pocket | 68 (57.6) |
| Desktop | 76 (64.4) |
| Wardrobe | 21 (17.8) |
| Case | 15 (12.7) |
| Yes | 102 (86.4) |
| No | 16 (13.6) |
| Yes | 64 (54.2) |
| No | 54 (45.8) |
| Yes | 39 (33) |
| No | 79 (67) |
| Yes | 20 (17) |
| No | 98 (83) |
| Yes | 15 (12.7) |
| No | 103 (87.3) |
| Yes | 2 (1.7) |
| No | 116 (98.3) |
| Yes | 92 (78) |
| No | 26 (22) |
| Yes | 27 (22.9) |
| No | 91 (77.1) |
SD, standard deviation; ICU, intensive care unit.
Frequency of bacterial colonization by gram-positive cocci in dermatoscopes and smartphone adapters.
| Variable | Frequency (%) | 95% CI | |
|---|---|---|---|
| Bacterial growth in the dermatoscope (lens or on/off button) | 70/118 | 59.3 | 49.9 |
| Bacterial growth in the lens | 55/118 | 46.6 | 37.4 |
| Bacterial growth on the on/off button | 44/118 | 37.3 | 28.6 |
| Bacterial growth on smartphone adapter | 10/27 | 37 | 19.4 |
CI, confidence interval.
Categorical variables and their relation to the presence of bacterial contamination on the lens or on the on/off button.
| Variable | Frequency ( | Contamination by gram positive cocci (%) | |
|---|---|---|---|
| 0.581 | |||
| Male | 11 | 68.8 | |
| Female | 59 | 57.8 | |
| 0.013 | |||
| Yes | 33 | 75 | |
| No | 37 | 50 | |
| 0.010 | |||
| Private office | 20 | 42.6 | |
| Hospital | 18 | 72 | |
| Private office and hospital | 32 | 69.6 | |
| 0.005 | |||
| Only private office | 20 | 42.6 | |
| Only hospital or private office plus hospital | 50 | 70.4 | |
| 0.361 | |||
| DL100 and DL200 | 4 | 50 | |
| DL3, DL4, Veos Canfield | 37 | 62.7 | |
| Hybrid | 26 | 61.9 | |
| Wellch Allyn or Heine | 3 | 33.3 | |
| 0.676 | |||
| Yes | 56 | 60.9 | |
| No | 14 | 53.8 | |
| 0.019 | |||
| Yes | 47 | 69.1 | |
| No | 23 | 46 | |
| 0.819 | |||
| Yes | 44 | 57.9 | |
| No | 26 | 61.9 | |
| 0.999 | |||
| Yes | 12 | 57.1 | |
| No | 58 | 59.8 | |
| 0.735 | |||
| Yes | 10 | 66.7 | |
| No | 60 | 58.3 | |
| 0.272 | |||
| Yes | 58 | 56.9 | |
| No | 12 | 75.0 | |
| 0.001 | |||
| Yes | 47 | 73.4 | |
| No | 23 | 42.6 | |
| <0.001 | |||
| Yes | 33 | 84.6 | |
| No | 37 | 46.8 | |
| <0.001 | |||
| Yes | 20 | 100 | |
| No | 50 | 51 | |
| 0.143 | |||
| Yes | 12 | 80 | |
| No | 58 | 56.3 | |
| 0.513 | |||
| Yes | 2 | 100 | |
| No | 68 | 58.6 | |
| 0.348 | |||
| Yes | 52 | 56.5 | |
| No | 18 | 69.2 | |
| 0.999 | |||
| Yes | 16 | 59.3 | |
| No | 54 | 59.3 | |
ICU, intensive care unit.
Chi-squared test.
Fisher's exact test.
Figure 2Age of dermatologists and their relation to the presence or absence of bacterial contamination on dermatoscopes. Statistic Test: Student t-test. Standard deviation in the group with gram-positive cocci 6.4. Standard deviation in the group without gram-positive cocci 9.8.
Numerical variables and their relation to the presence or absence of bacterial contamination on the lens or on the on/off button.
| Variable | Presence of gram-positive median cocci (interquartile range) | Absence of gram-positive-median cocci (interquartile range) | |
|---|---|---|---|
| Time as a dermatologist, years | 4 (1 | 11 (4.25 | <0.001 |
| Number of times the dermatoscope is used per day | 15 (10 | 10 (10 | 0.004 |
| Number of patients seen per day | 20 (15 | 15.5 (12.25 | 0.035 |
| Dermoscopy time per consultation, minutes | 5 (3 | 5 (3 | 0.881 |
| How many times a day do you access your mobile phone? | 10 (4.75 | 10 (5 | 0.862 |
Statistical test used: Mann–Whitney test.
Figure 3Gram-positive cocci identified by MALDI-TOF MS.
Antimicrobial resistance profile of gram-positive cocci isolates obtained from dermatoscopes and smartphone adapters.
| Gram-positive cocci | ||||
|---|---|---|---|---|
| Sensitivity | Resistance | |||
| Antibiotic | % | % | ||
| Penicillin | 26 | 23.6 | 84 | 77.4 |
| Erythromycin | 31 | 28.4 | 78 | 71.6 |
| Clindamycin | 75 | 68.8 | 34 | 31.2 |
| Tetracycline | 95 | 86.4 | 15 | 13.6 |
| SMT-TMP | 66 | 60.6 | 43 | 39.4 |
| Cefoxitin | 103 | 93.6 | 7 | 6.4 |
| Gentamicin | 104 | 94.5 | 6 | 5.5 |
| Rifampicin | 105 | 95.4 | 5 | 4.6 |
| Levofloxacin | 103 | 93.6 | 7 | 6.4 |
| Linezolid | 110 | 100 | 0 | 0 |
SMT-TMP, sulfamethoxazole-trimethoprim.
Antimicrobial resistance profile of the isolates of the most frequent gram-positive cocci obtained from dermatoscopes and smartphone adapters.
| Frequency of resistance among gram-positive cocci (%) | |||||
|---|---|---|---|---|---|
| Antibiotic | |||||
| Penicillin | 79.4 | 50 | 88.9 | 75 | 100 |
| Erythromycin | 73.6 | 83.3 | 55.6 | 50 | 80 |
| Clindamycin | 36.6 | 25 | 11.1 | 0 | 40 |
| Tetracycline | 15.1 | 8.3 | 0 | 25 | 40 |
| SMT-TMP | 44.4 | 25 | 22.2 | 50 | 60 |
| Cefoxitin | 6.8 | 0 | 0 | 25 | 20 |
| Gentamicin | 5.5 | 0 | 0 | 0 | 40 |
| Rifampicin | 4.1 | 0 | 0 | 25 | 0 |
| Levofloxacin | 5.5 | 0 | 0 | 75 | 0 |
| Linezolid | 0 | 0 | 0 | 0 | 0 |
SMT-TMP, sulfametoxazol-trimetropim.